The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and Reckitt, ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

In the first case to go to trial in March, Reckitt Benckiser was ordered to pay $60 million in damages to a mother whose ...

Harvey Jones rejected any thought of buying this former FTSE 100 darling in August but after some positive news should he now revise his opinion? The post After jumping 10% this morning is this hated ...

Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...

Reckitt saw sales surpass expectations in the third quarter as the consumer giant was boosted by healthcare brands, including ...

These three UK shares have been dragged down and our writer believes they're trading below their true value as we enter ...

The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.

Rob Dobson, director at S&P Global Market Intelligence, said: “UK manufacturing started the final quarter of the year on an ...

A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...

The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.